Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

Novartis has presented new data from the Phase III NATALEE trial at ASCO 2025, showcasing Kisqali’s ability to reduce the risk of recurrence in ...

Breast cancer patients whose tumors have spread to other parts of their bodies live from scan to scan. Is their treatment ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated ...

About the expert Laura Dean, MD, is a board-certified diagnostic radiologist at Cleveland Clinic, where she has been practicing since 2014. She completed her residency at Northwestern University’s ...

Radiologists interpret more than 40 million mammograms in the United States every year. In 2025, AI tools to help detect or ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

Citing what they called an “unspeakable tragedy,” health officials were joined by Sen. Richard Blumenthal this week to raise ...